WO2021254009A1 - Method for detecting trace nucleic acids in various mixed nucleic acids - Google Patents

Method for detecting trace nucleic acids in various mixed nucleic acids Download PDF

Info

Publication number
WO2021254009A1
WO2021254009A1 PCT/CN2021/091723 CN2021091723W WO2021254009A1 WO 2021254009 A1 WO2021254009 A1 WO 2021254009A1 CN 2021091723 W CN2021091723 W CN 2021091723W WO 2021254009 A1 WO2021254009 A1 WO 2021254009A1
Authority
WO
WIPO (PCT)
Prior art keywords
nucleic acid
linear
circular
detecting trace
rolling circle
Prior art date
Application number
PCT/CN2021/091723
Other languages
French (fr)
Chinese (zh)
Inventor
李凯
廖端芳
肖莉
张安迪
邢春根
Original Assignee
李凯
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 李凯 filed Critical 李凯
Publication of WO2021254009A1 publication Critical patent/WO2021254009A1/en

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions

Definitions

  • the patent of the present invention relates to the field of biomedicine, in particular to a nucleic acid analysis technology, in particular to the use of endonuclease to selectively break specific circular nucleic acids to achieve amplification and enrichment of unbroken nucleic acid molecules Technology.
  • Nucleic acid analysis and enrichment are of great significance in the analysis of gene mutations.
  • Polymerase chain reaction PCR, ligase chain reaction LCR and rolling circle amplification RCA have the effect of selective amplification of nucleic acids in specific regions, and can also be used for whole genome amplification.
  • somatic mutations are due to most cases, especially somatic mutations in biological specimens such as blood, urine, sputum, complex specimens of mixed hosts and parasitic microorganisms, and environmental testing such as water and air specific mutation pathogens Due to the large proportion of nucleic acid components that do not need to be analyzed, or the content of mutant nucleic acids is much lower than that of wild genes, the nucleic acid molecules of different genotypes can be selectively distinguished and the enrichment content is low or the content is extremely low.
  • the mutant gene fragment has a certain practical value.
  • biotechnologies can be used for the enrichment of specific genotypes, such as a mutation-sensitive molecular switch composed of exonuclease-resistant sulfur-modified primers and high-fidelity DNA polymerase (1), designed for blue and white colonies with stop codons Enrichment technology (2), an enrichment system (3) composed of a combination of suicide gene and homicide gene, and digestion and amplification technology (4-6) coupled with thermostable restriction endonuclease and polymerase (4-6), both can be used Enrichment of mutant nucleic acids with specific properties under certain conditions.
  • nucleic acid enrichment technology with higher enrichment efficiency and wider application range is still a practical technology to be developed in the field of biotechnology.
  • the technical problem to be solved by the present invention is to provide a nucleic acid analysis technique for detecting trace nucleic acids from a variety of mixed nucleic acids, so as to achieve the purpose of high efficiency and distinguishing both hereditary mutations and epimutations.
  • the technical solution provided by the present invention is: a method for detecting trace nucleic acids from a variety of mixed nucleic acids, which includes the following steps:
  • nuclease with endonuclease function to selectively break the circularized nucleic acid, so that the nucleic acid target that does not need to be enriched in the sample to be tested changes from a circular nucleic acid to a linear nucleic acid.
  • step (3) Detect and identify the nucleic acid molecules obtained in step (2), and detect whether the remaining form is linear nucleic acid or circular nucleic acid.
  • the nucleic acid target to be identified and enriched is a large number of unknowns with different lengths
  • step (1) first fill in the end of the linear nucleic acid molecule in the sample to be tested to fill in A, and then use the nucleic acid
  • the ligase links the linker to form a circularized nucleic acid.
  • the nucleic acid to be identified and enriched is a known and determined number of targets
  • the endonuclease processes the amplified product and nucleic acid ligase to form circular nucleic acid.
  • the nucleic acid to be enriched is a known number of targets
  • a primer with a LoxP site at the 5'end is used for amplification, and then the recombination function of cre recombinase is used to form Circularized nucleic acid.
  • the linear nucleic acid molecule is circularized with a nuclease capable of connecting linear nucleic acids into a circle. More preferably, the nuclease is a nucleic acid ligase.
  • the nuclease with endonuclease function is a natural endonuclease; in another preferred technical solution of the present invention, the nuclease with endonuclease function is a genetic engineering endonuclease. Dicer.
  • the method for identifying whether the remaining form of the nucleic acid molecule to be tested is linear or circular, including electrophoresis, exonuclease exonuclease, PCR amplification, rolling circle amplification, and flying Mass spectrometry, high pressure liquid phase method, high resolution dissolution curve.
  • rolling circle amplification is performed on the sample to be tested after selective destruction.
  • the rolling circle amplification adopts one-way rolling circle amplification or two-way rolling circle amplification.
  • random primers or specific primers are used for rolling circle amplification.
  • exonuclease exonuclease method uses exonuclease V to digest linear nucleic acids.
  • exonuclease V digested specimens are amplified by PCR.
  • the method of the present invention can be used for qualitative and quantitative analysis of nucleic acid.
  • Nucleic acid loops use nucleases that have the ability to connect nucleic acid molecules.
  • T4 nucleic acid ligase The high-temperature-resistant nucleic acid ligase itself has been used for nucleic acid analysis in the ligase chain reaction. But for T4DNA ligase that is not resistant to high temperatures, it is mainly used for subcloning, ligation of sequencing adapters in library preparation, etc.
  • the linker adopts a hairpin structure, the double-stranded linear nucleic acid molecule forms a single loop structure after being connected to the linker. This looping method by connecting linkers can be used for gene mutation analysis at the omics level.
  • the combined mutation analysis of hotspot mutations also has a wide range of applications.
  • the amplified product of a specific known site by introducing a restriction enzyme cleavage site at the end of primer 5, the amplified product is digested with restriction enzyme, and both ends of the amplified product are formed after restriction enzyme digestion
  • nucleic acid ligase can make it form a double-stranded circular nucleic acid molecule.
  • the inventors used restriction enzyme digestion of PCR amplified products and further dephosphorylated the digested products, which substantially improved the enrichment of mutant fragments by blue and white colony technology. (6).
  • the technology of the present invention adopts a brand-new technical solution, and the nucleic acid fragment to be tested is first circularized. , And then selectively destroy a specific type of circular nucleic acid to distinguish whether the existence form of the test molecule is circular or linear.
  • the present invention Compared with the existing high-throughput sequencing library preparation technology, the present invention has the advantages of a wide application range, which can be used for both the enrichment of genetic mutations and the discrimination of methylation mutations, and the advantages of being used for further enrichment after discrimination. It has certain practical value in many fields such as biomedicine and environmental monitoring.
  • Nucleic acid amplification can have a variety of techniques, among which rolling circle amplification and PCR amplification have been widely used.
  • Rolling circle amplification is an in vitro application technology of natural rolling circle replication.
  • the main purpose of rolling circle amplification is not mutation enrichment.
  • the invention combines nucleic acid ring formation and ring destruction, which expands the application range for rolling circle amplification. Loop formation and selective destruction are the core of the present invention, which can distinguish nucleic acid molecules of specific genotypes, and provide a template that has been enriched and distinguished for PCR amplification and rolling circle amplification.
  • ring formation is a non-selective process
  • ring breaking is a selective process.
  • endonucleases can cut nucleic acids at the non-end of the nucleic acid.
  • One option for breaking the ring is through the use of restriction endonucleases, such as MseI and NciI.
  • Another option for the selective implementation of ring breaking is to use endonucleases that have no sequence specificity, such as cas9, Agonaute, T7E1, UDG, etc.
  • the selectivity of these enzymes is determined by selective guide RNA fragments. It is determined by the small fragments of guiding DNA and the uracil residues that convert the unmethylated cytosine C on the circular nucleic acid.
  • the sample after selective destruction can preferably be amplified by rolling circle.
  • PCR amplification is the most widely used in the field of nucleic acid amplification.
  • the specimen to be tested is distinguished between linear nucleic acid and circular nucleic acid by exonuclease, such as exonuclease V (endonuclease V), which degrades linear nucleic acid and retains circular nucleic acid.
  • exonuclease V exonuclease V
  • the sample to be tested after the linear nucleic acid is degraded can preferably be amplified by PCR.
  • the present invention directly uses electrophoresis to distinguish circular and linear nucleic acids for the specimens to be analyzed with a higher copy number by coupling ring-breaking.
  • the invention has certain application value in the analysis of animal and plant gene mutations and epigenetic mutations, and has certain application value in the monitoring of mutations of pathogenic microorganisms.
  • the invented technology adopts a brand-new technical scheme.
  • the nucleic acid fragment to be tested is circularized, and then a specific type of circular nucleic acid is selectively destroyed, so as to distinguish whether the existence form of the molecule to be tested is circular or linear.
  • This difference can be confirmed directly by the migration speed of nucleic acid electrophoresis; it can also be further processed by digesting linear nucleic acid and exonuclease V that retains circular nucleic acid to relatively enrich circular nucleic acid molecules; or by rolling circle amplification for circular nucleic acid
  • the genotype corresponding to the molecule is amplified and enriched in absolute copy number.
  • the patent of the present invention Compared with the existing high-throughput sequencing library preparation technology, the patent of the present invention has the advantages of high enrichment efficiency and wide application range. It can be used for the enrichment of genetic mutations and methylation mutations. Many fields such as biomedicine and environmental monitoring have practical value.
  • Figure 1A is a schematic diagram of the detection method of the present invention and its downstream application flow.
  • the cyclization and selective decyclization in the dashed box on the left side of FIG. 1 are the technical core of the present invention.
  • This technology can achieve the different states of the nucleic acid molecules of the test specimen into circular and linear states.
  • the downstream applications on the right show multiple application scenarios for distinguishing circular and linear nucleic acid molecules.
  • the other techniques can be flight mass spectrometry, high pressure liquid phase, high resolution dissolution curve, etc.
  • Fig. 1B is a schematic diagram of another process of the detection method of the present invention. It shows that in the analysis of free nucleic acids in the blood, the linear molecules of specific genotypes can be enriched by the combined application of looping/breaking and rolling circle amplification, and the products after rolling circle amplification can be sequenced and analyzed in one step.
  • Figure 2A Ring-forming and ring-breaking recognition of methylated and non-methylated synthetic templates.
  • Figure 2B shows the results of rolling circle amplification of methylated and unmethylated synthetic fragments after ring formation and destruction.
  • Fig. 3A shows the ring formation of the artificial methylated and non-methylated templates containing the three-terminal protruding A tail of Example 2.
  • Fig. 3B shows the rolling circle amplification after the destruction of the artificial methylated and unmethylated templates containing the three-terminal protruding A tail in Example 2.
  • Fig. 4 shows the loop-forming and breaking-recognition of the EGFR18 base deletion mutation in Example 3.
  • Fig. 5A is an electrophoresis diagram of rolling circle amplification in Example 4.
  • Fig. 5B is a sequence diagram of PCR amplification products of the mutant mixed specimen of Example 4.
  • Fig. 6A is an electrophoresis diagram of rolling circle amplification in Example 5.
  • FIG. 6B is a sequence diagram of PCR amplification products of the mutant mixed specimen of Example 5.
  • FIG. 6B is a sequence diagram of PCR amplification products of the mutant mixed specimen of Example 5.
  • Example 1 Artificial synthesis of 53-base-length methylated template and non-methylated template for loop-breaking recognition and rolling circle amplification
  • the 1.53bp methylated and unmethylated fragments are synthesized by Sangong Chemical, and their 5'phosphorylation is modified.
  • the sequence of the synthesized fragment is as follows: Four primers are synthesized in the methylated region of Septin9, and the 5 end is phosphorylated, and /imedc/ is marked as A Base modification
  • the artificial template is characterized by flanking sticky ends containing more than 20 bases at both ends.
  • the purpose of this design is to improve the efficiency of ligase loop formation and to test the feasibility of looping/breaking.
  • Methylated and unmethylated fragments were dissolved in deionized water with a final concentration of 100 ⁇ m. Take 2ul of methylated template, 2ul of unmethylated template, and a portion containing one-thousandth methylated template and one thousandth.
  • the mixed template of 999 non-methylated templates is used for ligation reaction, and the reaction system is as follows:
  • Reaction conditions 25°C, 2h; then 70°C, 20min, to inactivate T4 DNA ligase.
  • Figure 2A Ring-forming and ring-breaking recognition of methylated and non-methylated synthetic templates.
  • Lane 1 from left to right is the nucleic acid size marker, and the smallest band is 100 bases. In increments of 100, the brightest band is 500 bases.
  • Lanes 2, 3 are the products after the methylation membrane plate is connected and the products after AciI digestion;
  • Lanes 4 and 5 are the products after the unmethylated template is connected and the products after AciI digestion;
  • Lanes 6, 7 are the products containing thousands of points
  • the mixed template of one of the methylated fragments is the product after ligation and AciI digestion.
  • the synthesized fragment is 53 bases, and under the action of ligase, a single-copy to multi-copy circular structure with 53 as the basic unit is formed.
  • Circular nucleic acids migrate slower than linear nucleic acids under the conditions of electrophoresis in this experiment. After AciI digestion, the methylated ring structure is not affected, and the unmethylated ring structure is degraded into a linear structure with 53 bases, 106 bases, and 159 bases. These linear fragments migrate faster under the electrophoretic field than the correspondingly sized circular structures. Through the coupling of ring formation and destruction, the methylated and unmethylated nucleic acid fragments are distinguished.
  • the amplification kit was purchased from Xinhai Gene Corporation (lot number A3702), and the system is as follows:
  • Figure 2B Rolling circle amplification results of methylated and non-methylated synthetic fragments after ring formation and destruction.
  • Lane 1 is the nucleic acid size reference marker, the smallest band is 100 bases, and the brightest band is 500 bases.
  • Lanes 2, 3, and 4 are the products after rolling circle amplification of methylated specimens, unmethylated specimens, and mixed specimens containing 1/1000 methylated fragments, respectively. Compared with unmethylated specimens, methylated specimens have significantly more amplified products. The amplified product of the mixed specimen (lane 4) was also significantly more than that of the unmethylated specimen (lane 3).
  • Example 2 Artificial synthesis of 34-base long methylated template and non-methylated template after looping/breaking of rolling circle amplification enrichment
  • the template sequence is as follows:
  • Non-A 3 Cac gtc cgc gcc ggg cat aca tta tac gaa gtt a (SEQ ID No. 7)
  • Non-A 4 Aac ttc gta taa tgt atg ccc ggc gcg gac gtg a (SEQ ID No. 8)
  • the hairpin linker sequence is as follows: P-aaa aaa aaa aaa aag/i5medc/a/i5medc/a/i5medc/i5medc/gta/i5medc/t/i5medc/t/i5medc/i5medc/gagttggatg/i5medc/ tgg atg gtt ttt ttttt t (SEQ ID No. 9). After confirming that the gel electrophoresis can observe the changes in ring formation and destruction, this set of templates and hairpin adapters were synthesized to simulate the actual situation of gene detection of free nucleic acids in the blood.
  • connection reaction system is as follows:
  • Reaction conditions 25°C, 2h; then 70°C, 20min, to inactivate T4 DNA ligase.
  • Figure 3A The first lane on the left is the 100-base DNA size marker, and the two brightest bands are 500 and 1000 bases, respectively.
  • Lanes 2, 5, and 7 are the mixture of short template and linker; after ligase linking, the linear template and two linkers are connected to form a circular structure, which is located near the size of the 100 base reference substance (lanes 3, 6, 9); the middle band is After the hairpin-shaped product connected to the template and a linker, after digestion with the restriction enzyme AciI, only the ring molecule formed by the methylated template still maintains the ring structure (lane 4).
  • the loop structure formed by the unmethylated short template and the linker becomes linear again after AciI digestion, and two small fragments with a difference of 14 bases in molecular size overlap the same gel band.
  • the smallest band still visible after ligase ligation and AciI digestion is the excess linker molecule.
  • the amplification kit was purchased from Xinhai Gene Corporation (lot number A3702), and the system is as follows:
  • Figure 3B shows the rolling circle amplification after the ring is broken.
  • a mixed sample containing one-thousandth of a methylated template yields visible amplification products (lane 2); pure methylated samples have the most amplification products (lane 4). There was almost no amplification product in the pure unmethylated template (lane 3).
  • test template prepare wild type, mutant type and 50% to 50% as test specimens.
  • the template sequences are:
  • primer sequences are:
  • Reverse primer ggaggaaTTC GAGTTGGATGCTGGATGG agaaa ctc acat cgagg atttc (SEQ ID No. 14) (the underline in the figure is the EcoRI restriction site).
  • the PCR reaction program is: 98°C, 30s; 98°C, 10s, 60°C, 15s, 72°C, 10s; 72°C, 3 minutes; the number of cycles is 35 times.
  • Pre-preparation of guide RNA Use an in vitro transcription kit to transform the DNA template of guide RNA, and store it in aliquots at -80°C after purification.
  • Carry out Cas9 nuclease in vitro digestion reaction add 250ng guide RNA and 100ng Cas9 protein (Cas9 nuclease, S.pyogenes, NEB#M0386M) to the above digestion system, 37°C, 2 hours, then 70°C, 20 minutes, The Cas9 protein loses its activity.
  • Figure 4 shows the ring-forming and breaking recognition of EGFR18 base deletion mutations.
  • Lane 1 is the nucleic acid size marker.
  • Lanes 2, 5, and 8 are PCR products in a linear state.
  • Lanes 3, 6, and 9 are the circular DNA linked by ligase, and the bands are lagging behind the linear DNA.
  • Lanes 4, 7, and 10 are the products after cas9 digestion. The mutant products are not digested by cas9 (lane 4); wild products are digested by cas9
  • the circular DNA becomes linear (lane 7); the part of the circular DNA obtained from the wild mutant half of the template becomes linear, showing two nucleic acid bands (lane 10). Nucleic acid looping/breaking can distinguish EGFR18 base mutations from wild fragments.
  • Example 4 EGFR18 base deletion mutation analysis, cas9 digestion, containing one-thousandth mutation, rolling circle amplification first-generation sequencing
  • primer sequences are:
  • Reverse primer ggaggaaTTC GAGTTGGATGCTGGATGG agaaa ctc acat cgagg atttc (SEQ ID No. 14) (the underline in the figure indicates the EcoRI restriction site).
  • the PCR reaction conditions are as follows:
  • the PCR reaction program is: 98°C, 30s; 98°C, 10s, 60°C, 15s, 72°C, 10s; 72°C, 3 minutes; the number of cycles is 35 times.
  • Pre-preparation of guide RNA Use an in vitro transcription kit to transform the DNA template of guide RNA, and store it in aliquots at -80°C after purification.
  • Carry out Cas9 nuclease in vitro digestion reaction add 250ng guide RNA and 100ng Cas9 protein (Cas9 nuclease, S.pyogenes, NEB#M0386M) to the above digestion system, 37°C, 2 hours, then 70°C, 20 minutes, The Cas9 protein loses its activity.
  • the amplification kit was purchased from Xinhai Gene Corporation (batch number A3702). The system is as follows:
  • the final PCR amplification product of the mixed sample containing one-thousandth mutation is sent to the company for first-generation sequencing.
  • the sequencing result is shown in Figure 5B.
  • Sequencing diagram The first-generation sequencing result shows that the sample containing one-thousandth mutation template is the product of rolling circle amplification. Appears as a single peak of the mutant sequence. It shows that after the three steps of looping/breaking/rolling circle amplification, the mutant fragments are enriched.
  • TCTCCCTCCCTCCAGGAAGCCTACGTGATGGCCAGCGTGGACAACCCCCACGTGTGCCGCCTGCTGGGCATCTGCCTCACCTCCACCGTGCAGCTCATCA T GCAGCTCATGCCCTTCGGCTGCCTCCTGGACTATGTCCGGGAACACAAAGACAATATTGGCTCCCAGTACCTGCTCAACTGGTG is the base line in the figure with the base line No. in the SEQ ID No.
  • primer sequences are:
  • Reverse primer GGAG GAATTC GTTATCAGTTATAGCCGAAGGGCATGAGCTCC (SEQ ID No. 18) (marked as EcoRI restriction site in the figure, C is the introduced mutation base).
  • the PCR reaction conditions are as follows:
  • the PCR reaction program is: pre-denaturation: 95°C, 3min; 95°C, 20s, 58°C, 20s, 72°C, 20s; 72°C, 3min; the number of cycles is 35 times.
  • Reaction procedure 95°C, 3 minutes; 25°C, 5 minutes; adding BSA and phi29, 30°C, 14 hours.
  • Lane 2 is a mixed template containing one-thousandth mutations
  • Lane 3 is a mutant template
  • Lane 4 is a wild template. Wild template amplification products are the least.
  • the first lane on the left is the kb DNA marker.
  • Figure 6B After sequencing, the rolling circle amplification product of the mixed sample containing 0.1% mutant template was confirmed to be derived from the mutant template and did not show a mixed set of peaks, indicating that the content of mutant molecules in the amplified product was enriched.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Disclosed in the present invention is a method for detecting trace nucleic acids by means of nucleic acid cyclization and selective nucleic acid disruption. The method comprises performing a cyclization treatment on a to-be-detected gene fragment and selectively performing a disruption treatment on a specific circular gene fragment. Different nucleic acid molecules respectively exhibit a circular state and a linear state by means of cyclization and a selective disruption treatment so as to be distinguished, and the technology can be used for identifying specific genotype nucleic acid molecules.

Description

多种混合核酸中检测痕量核酸的方法Methods for detecting trace amounts of nucleic acids in a variety of mixed nucleic acids 技术领域Technical field
本发明专利涉及生物医药领域,具体涉及一种核酸分析技术,特别涉及一种利用核酸酶内切酶选择性破环特定环状核酸以达到对未被破环的核酸分子进行扩增和富集的技术。The patent of the present invention relates to the field of biomedicine, in particular to a nucleic acid analysis technology, in particular to the use of endonuclease to selectively break specific circular nucleic acids to achieve amplification and enrichment of unbroken nucleic acid molecules Technology.
背景技术Background technique
核酸分析和富集在基因突变的分析中意义重大。聚合酶链式反应PCR,连接酶链式反应LCR和滚环扩增RCA等技术具有对特定区域的核酸选择性扩增的效果,也可用于全基因组扩增。但是,对体细胞突变的分析,由于大部分情况尤其是如血液,尿液,痰液等生物标本中的体细胞突变,混合宿主和寄生微生物的复杂标本,和环境检测如水和空气特定突变病原体的监控等情形,由于不需要分析的核酸成分所占比例太大,或突变核酸含量远远低于野生基因的含量,选择性区分不同基因型的核酸分子和富集含量较低或含量极低的突变基因片段,具有一定实用价值。Nucleic acid analysis and enrichment are of great significance in the analysis of gene mutations. Polymerase chain reaction PCR, ligase chain reaction LCR and rolling circle amplification RCA have the effect of selective amplification of nucleic acids in specific regions, and can also be used for whole genome amplification. However, the analysis of somatic mutations is due to most cases, especially somatic mutations in biological specimens such as blood, urine, sputum, complex specimens of mixed hosts and parasitic microorganisms, and environmental testing such as water and air specific mutation pathogens Due to the large proportion of nucleic acid components that do not need to be analyzed, or the content of mutant nucleic acids is much lower than that of wild genes, the nucleic acid molecules of different genotypes can be selectively distinguished and the enrichment content is low or the content is extremely low. The mutant gene fragment has a certain practical value.
多种生物技术可用于特定基因型的富集,如由耐外切酶消化的硫化修饰引物与高保真DNA聚合酶组成的突变敏感性分子开关(1),针对设计终止密码子的蓝白菌落富集技术(2),自杀基因与他杀基因联合构成的富集体系(3),利用耐高温限制性内切酶与聚合酶偶联的边消化边扩增技术(4-6),均可以在一定条件下对特定性质的突变核酸进行富集。但更高富集效率和具有更广泛应用范围的核酸富集技术,迄今仍是生物技术领域有待发展的实用技术。A variety of biotechnologies can be used for the enrichment of specific genotypes, such as a mutation-sensitive molecular switch composed of exonuclease-resistant sulfur-modified primers and high-fidelity DNA polymerase (1), designed for blue and white colonies with stop codons Enrichment technology (2), an enrichment system (3) composed of a combination of suicide gene and homicide gene, and digestion and amplification technology (4-6) coupled with thermostable restriction endonuclease and polymerase (4-6), both can be used Enrichment of mutant nucleic acids with specific properties under certain conditions. However, nucleic acid enrichment technology with higher enrichment efficiency and wider application range is still a practical technology to be developed in the field of biotechnology.
鉴于特定基因型的富集方法中,包括耐高温限制性内切酶的种类有限和去磷酸化处理及菌落斑技术在通量上的局限和比较费时等不足或缺点,为解决上述本发明由此而来。In view of the shortcomings or shortcomings of the specific genotype enrichment methods, including the limited types of high-temperature restriction endonucleases, the dephosphorylation treatment, and the limitation of the flux of the colony spot technology and the relatively time-consuming, etc., in order to solve the above-mentioned problems of the present invention From here.
发明内容Summary of the invention
本发明所要解决的技术问题在于提供一种从多种混合核酸中检测痕量核酸的核酸分析技术,达到高效且既可以区分遗传性突变、也可以区分表观突变的目的。The technical problem to be solved by the present invention is to provide a nucleic acid analysis technique for detecting trace nucleic acids from a variety of mixed nucleic acids, so as to achieve the purpose of high efficiency and distinguishing both hereditary mutations and epimutations.
为解决上述技术问题,本发明提供的技术方案是:从多种混合核酸中检测痕量核酸的方法,其包括如下步骤:In order to solve the above technical problems, the technical solution provided by the present invention is: a method for detecting trace nucleic acids from a variety of mixed nucleic acids, which includes the following steps:
(1)对含有多种混合核酸的待测样本,进行线性核酸分子的环化,(1) Carry out the circularization of linear nucleic acid molecules on the sample to be tested containing a variety of mixed nucleic acids,
(2)采用具有核酸内切功能的核酸酶对对环化后的核酸进行选择性破环,使待测样本中不需要富集的核酸靶点从环形核酸变为线性核酸,(2) Use a nuclease with endonuclease function to selectively break the circularized nucleic acid, so that the nucleic acid target that does not need to be enriched in the sample to be tested changes from a circular nucleic acid to a linear nucleic acid.
(3)对步骤(2)得到的核酸分子进行检测识别,检测存留形态是线性核酸还是环形核酸。(3) Detect and identify the nucleic acid molecules obtained in step (2), and detect whether the remaining form is linear nucleic acid or circular nucleic acid.
优选地,当需要识别与富集的核酸靶点为大量长度不一的未知情况时,在步骤(1)前,先将待测样本中的线性核酸分子的末端填平补A,然后用核酸链接酶链接接头以形成环化核酸。Preferably, when the nucleic acid target to be identified and enriched is a large number of unknowns with different lengths, before step (1), first fill in the end of the linear nucleic acid molecule in the sample to be tested to fill in A, and then use the nucleic acid The ligase links the linker to form a circularized nucleic acid.
优选地,当需要识别与富集的核酸为已知确定数量的靶点时,在步骤(1)前,先采用5’末端带限制性内切酶位点的引物进行扩增,然后利用相应的内切酶处理扩增产物、核酸连接酶使其形成环化核酸。Preferably, when the nucleic acid to be identified and enriched is a known and determined number of targets, before step (1), first use primers with restriction enzyme sites at the 5'end for amplification, and then use the corresponding The endonuclease processes the amplified product and nucleic acid ligase to form circular nucleic acid.
优选地,当需要富集的核酸为已知的一定数量的靶点时,在步骤(1)前,采用5’末端带LoxP位点的引物进行扩增,然后利用cre重组酶的重组功能形成环化核酸。Preferably, when the nucleic acid to be enriched is a known number of targets, before step (1), a primer with a LoxP site at the 5'end is used for amplification, and then the recombination function of cre recombinase is used to form Circularized nucleic acid.
优选地,在步骤(1),用具有将线性核酸连接成环形的核酸酶,进行线性核酸分子进行环化处理。更优选地,所述核酸酶为核酸连接酶。Preferably, in step (1), the linear nucleic acid molecule is circularized with a nuclease capable of connecting linear nucleic acids into a circle. More preferably, the nuclease is a nucleic acid ligase.
优选地,在步骤(2),所述具有核酸内切功能的核酸酶为天然核酸内切酶;本发明又一优选技术方案中,所述具有核酸内切功能的核酸酶为基因工程核酸内切酶。Preferably, in step (2), the nuclease with endonuclease function is a natural endonuclease; in another preferred technical solution of the present invention, the nuclease with endonuclease function is a genetic engineering endonuclease. Dicer.
优选地,在步骤(3)中,对待测核酸分子进行识别的存留形态是线性还是环形的方法,包括电泳方法、核酸外切酶外切法、PCR扩增法、滚环扩增法、飞行质谱、高压液相法、高分辨溶解曲线。Preferably, in step (3), the method for identifying whether the remaining form of the nucleic acid molecule to be tested is linear or circular, including electrophoresis, exonuclease exonuclease, PCR amplification, rolling circle amplification, and flying Mass spectrometry, high pressure liquid phase method, high resolution dissolution curve.
作为本发明的优选方案,对选择性破环后的待测样本进行滚环扩增。所述滚环扩增采用单向滚环扩增或双向滚环扩增。优选地,滚环扩增采用随机引物或采用特异性引物。As a preferred solution of the present invention, rolling circle amplification is performed on the sample to be tested after selective destruction. The rolling circle amplification adopts one-way rolling circle amplification or two-way rolling circle amplification. Preferably, random primers or specific primers are used for rolling circle amplification.
核酸外切酶外切方法采用核酸外切酶V消化线性核酸、优选地,核酸外切酶V消化后的标本采用PCR扩增。The exonuclease exonuclease method uses exonuclease V to digest linear nucleic acids. Preferably, exonuclease V digested specimens are amplified by PCR.
本发明的方法可用于核酸定性和定量分析。The method of the present invention can be used for qualitative and quantitative analysis of nucleic acid.
核酸的成环采用具有连接核酸分子能力的核酸酶。目前生物技术中使用最广泛的是T4核酸连接酶。对具有耐高温的核酸连接酶本身,已在连接酶链式反应中用于核酸的分析。但对于不耐高温的T4DNA连接酶,主要用于亚克隆,文库制备中测序接头的连接等。当接头采用发夹结构时,双链线性核酸分子在连接上接头后,即形成单环结构。这种通过连接接头的成环方式,可用于组学层面的基因突变分析。Nucleic acid loops use nucleases that have the ability to connect nucleic acid molecules. Currently the most widely used in biotechnology is T4 nucleic acid ligase. The high-temperature-resistant nucleic acid ligase itself has been used for nucleic acid analysis in the ligase chain reaction. But for T4DNA ligase that is not resistant to high temperatures, it is mainly used for subcloning, ligation of sequencing adapters in library preparation, etc. When the linker adopts a hairpin structure, the double-stranded linear nucleic acid molecule forms a single loop structure after being connected to the linker. This looping method by connecting linkers can be used for gene mutation analysis at the omics level.
基因突变分析除组学层面的分析外,热点突变的组合突变分析,同样也有较广泛应用。对于特定已知位点扩增的产物,通过在引物5末端引入限制性酶切位点,对扩增产物进行限制性内切酶消化,扩增产物两端在限制性内切酶消化后形成可连接的末端,核酸连接酶可使其形成双链环形核酸分子。In addition to the omics level analysis of gene mutation analysis, the combined mutation analysis of hotspot mutations also has a wide range of applications. For the amplified product of a specific known site, by introducing a restriction enzyme cleavage site at the end of primer 5, the amplified product is digested with restriction enzyme, and both ends of the amplified product are formed after restriction enzyme digestion At the end that can be ligated, nucleic acid ligase can make it form a double-stranded circular nucleic acid molecule.
由于基因重组酶cre的效率高,使用简单,对多热点的组合文库制备,可以通过在序列特异性引物的5端加上测序序列和LoxP位点,保证PCR扩增后的产物两端的两个LoxP位点是相同方向,这样加入cre酶后两个LoxP位点发生基因重组,形成环状结构。Because the gene recombinase cre is highly efficient and easy to use, for the preparation of multi-hotspot combinatorial libraries, you can add sequencing sequence and LoxP sites to the 5 ends of sequence-specific primers to ensure that the two ends of the PCR amplified product The LoxP sites are in the same direction, so after the addition of cre enzyme, the two LoxP sites undergo gene recombination to form a circular structure.
在蓝白菌落富集突变研发中,发明人通过对PCR扩增的产物进行限制性内切酶消化并进一步进行消化产物的去磷酸化,实质性提高了蓝白菌落技术对突变片段的富集(6)。鉴于耐高温限制性内切酶的种类有限和去磷酸化处理及菌落斑技术在通量上的局限和比较费时等局限,本发明技术采用全新的技术方案,先对待测核酸片段进行环化处理,然后选择性破环特定类型的环状核酸,达到对待测分子的存在形式是环形还是线性而加以区别。这一区别可以(1)直接通过核酸电泳的迁移速度加以确认;(2)可以进一步通过核酸外切酶V消化线性核酸保留环形核酸的处理相对富集环形核酸分子;(3)可以对核酸外切酶V的产物进行PCR扩增进行富集;(4)或者对破环之后的产物直接进行滚环扩增达到使破环后仍保留为环形结构的基因型进行绝对拷贝数的放大和富集。In the research and development of blue and white colony enrichment mutations, the inventors used restriction enzyme digestion of PCR amplified products and further dephosphorylated the digested products, which substantially improved the enrichment of mutant fragments by blue and white colony technology. (6). In view of the limited types of heat-resistant restriction endonucleases and the limitations of dephosphorylation treatment and colony plaque technology in terms of throughput and relatively time-consuming limitations, the technology of the present invention adopts a brand-new technical solution, and the nucleic acid fragment to be tested is first circularized. , And then selectively destroy a specific type of circular nucleic acid to distinguish whether the existence form of the test molecule is circular or linear. This difference can be confirmed by (1) directly by the migration speed of nucleic acid electrophoresis; (2) can be further processed by exonuclease V digestion of linear nucleic acid to retain circular nucleic acid to relatively enrich circular nucleic acid molecules; (3) can be used for extranucleic acid The product of Dicer V is amplified by PCR for enrichment; (4) or the product after the broken circle is directly subjected to rolling circle amplification to achieve the absolute copy number amplification and enrichment of the genotype that remains in the ring structure after the broken circle. set.
与现有的高通量测序文库制备技术比较,本发明具有应用范围广既可以用于遗传性突变的富集也可用于甲基化突变的区分,和可用于区分后进一步富集的优势。在生物医学和环境监控等多个领域具有一定实用价值。Compared with the existing high-throughput sequencing library preparation technology, the present invention has the advantages of a wide application range, which can be used for both the enrichment of genetic mutations and the discrimination of methylation mutations, and the advantages of being used for further enrichment after discrimination. It has certain practical value in many fields such as biomedicine and environmental monitoring.
核酸扩增可以有多种技术,其中滚环扩增和PCR扩增均得到广泛应用。Nucleic acid amplification can have a variety of techniques, among which rolling circle amplification and PCR amplification have been widely used.
滚环扩增是天然滚环复制的体外应用性技术,作为PCR扩增技术之外的一种核酸扩增技术,效率高,在全基因扩增领域应用较广。滚环扩增的主要用途不是突变富集。本发明由核酸成环和破环相结合,为滚环扩增扩大了应用范围。成环与选择性破环是本发明的核心,可以区分特定基因型的核酸分子,为PCR扩增和滚环扩增提供已经富集区分开来的模板。在本发明中,成环是一个非选择性的过程,而破环则是一个选择性的过程。将环状核酸变为线性核酸只需对核酸环切开一个或一个以上的切口,与核酸外切酶不同,核酸内切酶都可以在核酸的非末端处对核酸进行剪切。破环的选择性一种方案是通过采用限制性核酸内切酶,如MseI、NciI。破环的选择性实施的另一种方案是采用本身没有序列特异性的核酸内切酶,如cas9,Agonaute,T7E1,UDG等,这些酶的选择性分别由选择性的指导RNA小片段,选择性的指导DNA小片段,和将环形核酸上的未甲基化的胞嘧啶C转化而来的尿嘧啶残基所决定。选择性破环后的标本可以优选地采用滚环扩增。Rolling circle amplification is an in vitro application technology of natural rolling circle replication. As a nucleic acid amplification technology in addition to PCR amplification technology, it has high efficiency and is widely used in the field of whole gene amplification. The main purpose of rolling circle amplification is not mutation enrichment. The invention combines nucleic acid ring formation and ring destruction, which expands the application range for rolling circle amplification. Loop formation and selective destruction are the core of the present invention, which can distinguish nucleic acid molecules of specific genotypes, and provide a template that has been enriched and distinguished for PCR amplification and rolling circle amplification. In the present invention, ring formation is a non-selective process, and ring breaking is a selective process. Turning a circular nucleic acid into a linear nucleic acid only needs to make one or more nicks on the nucleic acid circle. Unlike exonucleases, endonucleases can cut nucleic acids at the non-end of the nucleic acid. One option for breaking the ring is through the use of restriction endonucleases, such as MseI and NciI. Another option for the selective implementation of ring breaking is to use endonucleases that have no sequence specificity, such as cas9, Agonaute, T7E1, UDG, etc. The selectivity of these enzymes is determined by selective guide RNA fragments. It is determined by the small fragments of guiding DNA and the uracil residues that convert the unmethylated cytosine C on the circular nucleic acid. The sample after selective destruction can preferably be amplified by rolling circle.
PCR扩增在核酸扩增领域应用最为广泛。本发明的成环和破环之后,待测标本通过核酸外切酶对线性核酸与环形核酸的区分,如核酸外切酶V(endonuclease V),降解线性核酸,保留环形核酸。线性核酸被降解后的待测标本可以优选地采用PCR扩增。PCR amplification is the most widely used in the field of nucleic acid amplification. After the looping and breaking of the present invention, the specimen to be tested is distinguished between linear nucleic acid and circular nucleic acid by exonuclease, such as exonuclease V (endonuclease V), which degrades linear nucleic acid and retains circular nucleic acid. The sample to be tested after the linear nucleic acid is degraded can preferably be amplified by PCR.
本发明通过耦合成环-破环,对拷贝数较高的待分析标本,直接利用电泳区分环形与线性核酸进行区分。对拷贝数较低的有待富集的标本和靶点,通过选择性破环的处理,只有在破环处理后仍然保留环状的那些靶点核酸分子,才能在破环后的扩增阶段得到大量的扩增产物。从而达到对选择性富集特定分子的进一步扩增。本发明在动植物基因突变和表遗传突变的分析中具有一定应用价值,在病原微生物的突变监测方面具有一定应用价值。The present invention directly uses electrophoresis to distinguish circular and linear nucleic acids for the specimens to be analyzed with a higher copy number by coupling ring-breaking. For the specimens and targets with low copy number to be enriched, through selective destruction processing, only those target nucleic acid molecules that still retain the ring after the destruction can be obtained in the amplification stage after the destruction A lot of amplification products. So as to achieve the further amplification of the selective enrichment of specific molecules. The invention has certain application value in the analysis of animal and plant gene mutations and epigenetic mutations, and has certain application value in the monitoring of mutations of pathogenic microorganisms.
发明技术采用全新的技术方案,先对待测核酸片段进行环化处理,然后选择性破环特定类型的环状核酸,达到对待测分子的存在形式属于环形还是线性从而加以区别。这一区别可以直接通过核酸电泳的迁移速度加以确认;也可以进一步通过消化线性核酸、保留环形核酸的核酸外切酶V的处理,相对富集环形核酸分子;或者通过滚环扩增对环形核酸分子相对应的基因型进行绝对拷贝数的放大和富集。The invented technology adopts a brand-new technical scheme. First, the nucleic acid fragment to be tested is circularized, and then a specific type of circular nucleic acid is selectively destroyed, so as to distinguish whether the existence form of the molecule to be tested is circular or linear. This difference can be confirmed directly by the migration speed of nucleic acid electrophoresis; it can also be further processed by digesting linear nucleic acid and exonuclease V that retains circular nucleic acid to relatively enrich circular nucleic acid molecules; or by rolling circle amplification for circular nucleic acid The genotype corresponding to the molecule is amplified and enriched in absolute copy number.
与现有的高通量测序文库制备技术比较,本发明专利具有富集效率高、应用范围广,既可以用于遗传性突变的富集、也可用于甲基化突变富集的优势,在生物医学和环境监控等多个领域具有实用价值。Compared with the existing high-throughput sequencing library preparation technology, the patent of the present invention has the advantages of high enrichment efficiency and wide application range. It can be used for the enrichment of genetic mutations and methylation mutations. Many fields such as biomedicine and environmental monitoring have practical value.
附图说明Description of the drawings
下面结合附图及实施例对本发明作进一步描述:The present invention will be further described below in conjunction with the drawings and embodiments:
图1A为本发明检测方法和其下游应用流程示意图。图1左边虚线方框内的环化和选择性去环化是本发明的技术核心。该技术可以达到使待测标本核酸分子分别成为环形和线性的不同状态。右边下游应用显示区分环形与线性核酸分子的多种应用情形。其中的其他技术可以是飞行质谱,高压液相,高分辨溶解曲线等。Figure 1A is a schematic diagram of the detection method of the present invention and its downstream application flow. The cyclization and selective decyclization in the dashed box on the left side of FIG. 1 are the technical core of the present invention. This technology can achieve the different states of the nucleic acid molecules of the test specimen into circular and linear states. The downstream applications on the right show multiple application scenarios for distinguishing circular and linear nucleic acid molecules. The other techniques can be flight mass spectrometry, high pressure liquid phase, high resolution dissolution curve, etc.
图1B为本发明检测方法又一流程示意图。显示了血液中的游离核酸分析时,通过成环/破环与滚环扩增联合应用对特定基因型线性分子富集,滚环扩增后的产物可经一步进行测序分析。Fig. 1B is a schematic diagram of another process of the detection method of the present invention. It shows that in the analysis of free nucleic acids in the blood, the linear molecules of specific genotypes can be enriched by the combined application of looping/breaking and rolling circle amplification, and the products after rolling circle amplification can be sequenced and analyzed in one step.
图2A甲基化与非甲基化人工合成模板的成环与破环识别。Figure 2A: Ring-forming and ring-breaking recognition of methylated and non-methylated synthetic templates.
图2B为甲基化与非甲基化人工合成片段经过成环与破环处理后的滚环扩增结果。Figure 2B shows the results of rolling circle amplification of methylated and unmethylated synthetic fragments after ring formation and destruction.
图3A为实施例二的含三末端突出A尾部的人工甲基化与非甲基化模板的成环。Fig. 3A shows the ring formation of the artificial methylated and non-methylated templates containing the three-terminal protruding A tail of Example 2.
图3B为实施例二的含三末端突出A尾部的人工甲基化与非甲基化模板的破环后的滚环扩增。Fig. 3B shows the rolling circle amplification after the destruction of the artificial methylated and unmethylated templates containing the three-terminal protruding A tail in Example 2.
图4为实施例三EGFR18碱基缺失突变的成环破环识别。Fig. 4 shows the loop-forming and breaking-recognition of the EGFR18 base deletion mutation in Example 3.
图5A为实施例四的滚环扩增电泳图。Fig. 5A is an electrophoresis diagram of rolling circle amplification in Example 4.
图5B为实施例四的突变混合标本的PCR扩增产物测序图。Fig. 5B is a sequence diagram of PCR amplification products of the mutant mixed specimen of Example 4.
图6A为实施例五的滚环扩增电泳图。Fig. 6A is an electrophoresis diagram of rolling circle amplification in Example 5.
图6B为实施例五的突变混合标本的PCR扩增产物测序图。FIG. 6B is a sequence diagram of PCR amplification products of the mutant mixed specimen of Example 5. FIG.
具体实施方式detailed description
为使本发明的上述目的、特征和优点能够更加明显易懂,下面结合附图对本发明的具体实施方式做详细的说明。在下面的描述中阐述了很多具体细节以便于充分理解本发明。但是本发明能够以很多不同于在此描述的其它方式来实施,本领域技术人员可以在不违背本发明内涵的情况下做类似改进,因此本发明不受下面公开的具体实施例的限制。In order to make the above-mentioned objects, features and advantages of the present invention more obvious and understandable, the specific embodiments of the present invention will be described in detail below with reference to the accompanying drawings. In the following description, many specific details are explained in order to fully understand the present invention. However, the present invention can be implemented in many other ways different from those described herein, and those skilled in the art can make similar improvements without departing from the connotation of the present invention. Therefore, the present invention is not limited by the specific embodiments disclosed below.
除非另有定义,本文所使用的所有的技术和科学术语与属于本发明的技术领域的技术人员通常理解的含义相同。本文中在本发明的说明书中所使用的术语只是为了描述具体的实施例的目的,不是旨在于限制本发明。本文所使用的术语“及/或”包括一个或多个相关的所列项目的任意的和所有的组合。以下结合附图描述本发明具体实施方式。Unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood by those skilled in the technical field of the present invention. The terms used in the specification of the present invention herein are only for the purpose of describing specific embodiments, and are not intended to limit the present invention. The term "and/or" as used herein includes any and all combinations of one or more related listed items. The specific embodiments of the present invention will be described below in conjunction with the accompanying drawings.
实施例一:人工合成长度为53碱基的甲基化模板与非甲基化模板的成环破环识别和滚环扩增Example 1: Artificial synthesis of 53-base-length methylated template and non-methylated template for loop-breaking recognition and rolling circle amplification
1.53bp甲基化和非甲基化片段由生工化学合成,其5’磷酸化修饰,合成片段的序列如下:Septin9甲基化区域合成四条引物,5末端磷酸化,/imedc/标注为甲基化修饰The 1.53bp methylated and unmethylated fragments are synthesized by Sangong Chemical, and their 5'phosphorylation is modified. The sequence of the synthesized fragment is as follows: Four primers are synthesized in the methylated region of Septin9, and the 5 end is phosphorylated, and /imedc/ is marked as A Base modification
1.非甲基化模板1. Non-methylated template
1a:GATGGGAT CATTTCGGACGTATCATGTCGGACCCCGCGGTCAACGCGCAGCTG(SEQ ID No.1) 1a: GATGGGAT C ATTTCGGACGTATCATGTCGGACCCCGCGGTCAACGCGCAGCTG (SEQ ID No. 1)
2b:AcgtCCGAAATGATCCCATCCAGCTGCGCGTTGACCGCGGGGTCCGACATGAT(SEQ ID No.2)2b: AcgtCCGAAATGATCCCATCCAGCTGCGCGTTGACCGCGGGGTCCGACATGAT (SEQ ID No. 2)
2.甲基化模板2. Methylation template
3c:3c:
GATGGGATCATTTCGGA/i5MedC/gtatcatgtcggaccc/i5MedC/G/i5MedC/GGTCAA/i5MedC/G/i5MedC/GCAGCTG(SEQ ID No.3)GATGGGATCATTTCGGA/i5MedC/gtatcatgtcggaccc/i5MedC/G/i5MedC/GGTCAA/i5MedC/G/i5MedC/GCAGCTG(SEQ ID No.3)
4d:4d:
a/i5MedC/gtCCGAAATGATCCCATCCAGCTG/i5MedC/G/i5MedC/GTTGAC/i5MedC/G/i5MedC/GGGGTCCGACATGAT(SEQ ID No.4)a/i5MedC/gtCCGAAATGATCCCATCCAGCTG/i5MedC/G/i5MedC/GTTGAC/i5MedC/G/i5MedC/GGGGTCCGACATGAT(SEQ ID No.4)
该人工模板的特点是含有两端均含有超过20个碱基的侧翼粘性末端,此设计的目的是为了提高连接酶的成环效率,用以测试成环/破环的可行性。甲基化和非甲基化片段分别 溶解至去离子水中,终浓度为100μm,分别取2ul甲基化模板、2ul非甲基化模板以及一份含有千分之一甲基化模板与千分之九百九十九非甲基化模板的混合模板进行连接反应,反应体系如下:The artificial template is characterized by flanking sticky ends containing more than 20 bases at both ends. The purpose of this design is to improve the efficiency of ligase loop formation and to test the feasibility of looping/breaking. Methylated and unmethylated fragments were dissolved in deionized water with a final concentration of 100μm. Take 2ul of methylated template, 2ul of unmethylated template, and a portion containing one-thousandth methylated template and one thousandth. The mixed template of 999 non-methylated templates is used for ligation reaction, and the reaction system is as follows:
Figure PCTCN2021091723-appb-000001
Figure PCTCN2021091723-appb-000001
反应条件:25℃,2h;然后70℃,20min,使T4 DNA连接酶失去活性。Reaction conditions: 25°C, 2h; then 70°C, 20min, to inactivate T4 DNA ligase.
2.加入1μl AciI限制性内切酶酶切连接产物,37℃,2h,70℃,20min,使AciI内切酶失去活性。2. Add 1μl AciI restriction endonuclease to digest the ligation product, 37°C, 2h, 70°C, 20min to inactivate the AciI endonuclease.
3.将消化后的酶切产物进行凝胶电泳鉴定,电泳条件为100V,30min,2%琼脂糖凝胶。电泳结果见图2A。3. The digested products were identified by gel electrophoresis, the electrophoresis conditions were 100V, 30min, 2% agarose gel. The results of electrophoresis are shown in Figure 2A.
图2A甲基化与非甲基化人工合成模板的成环与破环识别。从左向右泳道1为核酸大小标志,最小条带为100碱基。以100为单位递增,最亮条带为500碱基。泳道2,3为甲基化膜版连接后的产物和AciI消化后的产物;泳道4,5为非甲基化模板连接后的产物和AciI消化后的产物;泳道6,7为含有千分之一甲基化片段的混合模板在连接后和AciI消化后的产物。合成片段为53个碱基,在连接酶作用下,形成以53为基本单位的单拷贝到多拷贝的环形结构。环形核酸在本实验电泳条件下迁徙速度较线性核酸慢。AciI消化后,甲基化的环形结构不受影响,非甲基化的环形结构降解为以53碱基,106碱基,159碱基为主的线性结构。这些线性片段电泳场下迁徙较相应大小的环形结构要快。通过成环和破环两个环节偶联,区分了甲基化和非甲基化核酸片段。Figure 2A: Ring-forming and ring-breaking recognition of methylated and non-methylated synthetic templates. Lane 1 from left to right is the nucleic acid size marker, and the smallest band is 100 bases. In increments of 100, the brightest band is 500 bases. Lanes 2, 3 are the products after the methylation membrane plate is connected and the products after AciI digestion; Lanes 4 and 5 are the products after the unmethylated template is connected and the products after AciI digestion; Lanes 6, 7 are the products containing thousands of points The mixed template of one of the methylated fragments is the product after ligation and AciI digestion. The synthesized fragment is 53 bases, and under the action of ligase, a single-copy to multi-copy circular structure with 53 as the basic unit is formed. Circular nucleic acids migrate slower than linear nucleic acids under the conditions of electrophoresis in this experiment. After AciI digestion, the methylated ring structure is not affected, and the unmethylated ring structure is degraded into a linear structure with 53 bases, 106 bases, and 159 bases. These linear fragments migrate faster under the electrophoretic field than the correspondingly sized circular structures. Through the coupling of ring formation and destruction, the methylated and unmethylated nucleic acid fragments are distinguished.
4.将上述酶切产物稀释1000倍,进行滚环扩增,扩增试剂盒购自新海基因公司(批号A3702),体系如下:4. Dilute the above-mentioned enzyme digestion product by 1000 times and carry out rolling circle amplification. The amplification kit was purchased from Xinhai Gene Corporation (lot number A3702), and the system is as follows:
Figure PCTCN2021091723-appb-000002
Figure PCTCN2021091723-appb-000002
Figure PCTCN2021091723-appb-000003
Figure PCTCN2021091723-appb-000003
反应程序:95℃,3min;25℃,5min;加入BSA与phi29,30℃,14h。Reaction procedure: 95°C, 3min; 25°C, 5min; adding BSA and phi29, 30°C, 14h.
5.取5ul滚环扩增产物进行电泳鉴定,电泳条件为100V,30min,0.8%浓度琼脂糖凝胶。电泳结果见图3B。5. Take 5ul of rolling circle amplification product for electrophoresis identification, electrophoresis conditions are 100V, 30min, 0.8% concentration agarose gel. The results of electrophoresis are shown in Figure 3B.
图2B:甲基化与非甲基化人工合成片段经过成环与破环处理后的滚环扩增结果。泳道1为核酸大小参照物标记,最小条带为100碱基,最亮条带为500碱基。泳道2,3,4分别为甲基化标本,非甲基化标本,和含有1/1000甲基化片段的混合标本的滚环扩增后的产物。与非甲基化标本比较,甲基化标本的扩增产物明显更多。混合标本的扩增产物(泳道4)也显著多于非甲基化标本(泳道3)的扩增产物。结果说明滚环扩增把成环与破环区别开来的线性与环形标本,进行了有区分的扩增,使选择性破环的限制性内切酶消化这一步骤转化为对特定基因型核酸分子拷贝数的放大。Figure 2B: Rolling circle amplification results of methylated and non-methylated synthetic fragments after ring formation and destruction. Lane 1 is the nucleic acid size reference marker, the smallest band is 100 bases, and the brightest band is 500 bases. Lanes 2, 3, and 4 are the products after rolling circle amplification of methylated specimens, unmethylated specimens, and mixed specimens containing 1/1000 methylated fragments, respectively. Compared with unmethylated specimens, methylated specimens have significantly more amplified products. The amplified product of the mixed specimen (lane 4) was also significantly more than that of the unmethylated specimen (lane 3). The results show that rolling circle amplification differentiates the linear and circular specimens from ring formation and destruction, and performs differentiated amplification, so that the restriction endonuclease digestion step for selective destruction is transformed into specific genotypes. Amplification of the copy number of nucleic acid molecules.
实施例二:人工合成长度为34碱基的甲基化模板与非甲基化模板成环/破环后的滚环扩增富集Example 2: Artificial synthesis of 34-base long methylated template and non-methylated template after looping/breaking of rolling circle amplification enrichment
分别取2μl甲基化模板、2μl非甲基化模板以及一份含有千分之一甲基化模板与千分之九百九十九非甲基化模板的混合模板,与发夹接头进行连接反应。模板序列如下:Take 2μl of methylated template, 2μl of unmethylated template, and a mixed template containing 1/1000 methylated template and 999/1000 unmethylated template, and connect them with hairpin adapters reaction. The template sequence is as follows:
四条引物,5末端磷酸化,/imedc/标注为甲基化修饰Four primers, 5 end phosphorylation, /imedc/ marked as methylation modification
全甲1:Cac gtc/i5medc/gc gcc ggg cat aca tta tac gaa gtt a(SEQ ID No.5)Full A1: Cacgtc/i5medc/gcgccgggcatacattatacgaagtta(SEQ ID No.5)
全甲2:Aac ttc gta taa tgt atg ccc ggc g/i5medc/g gac gtg a(SEQ ID No.6)Full A 2: Aac ttc gta taa tgt atg ccc ggc g/i5medc/g gac gtg a (SEQ ID No. 6)
非甲3:Cac gtc cgc gcc ggg cat aca tta tac gaa gtt a(SEQ ID No.7)Non-A 3: Cac gtc cgc gcc ggg cat aca tta tac gaa gtt a (SEQ ID No. 7)
非甲4:Aac ttc gta taa tgt atg ccc ggc gcg gac gtg a(SEQ ID No.8)Non-A 4: Aac ttc gta taa tgt atg ccc ggc gcg gac gtg a (SEQ ID No. 8)
发夹接头序列如下:P-aaa aaa aaa aag/i5medc/a/i5medc/a/i5medc/i5medc/gta/i5medc/t/i5medc/a/i5medc/t/i5medc/i5medc/gag ttg gat g/i5medc/tgg atg gtt ttt ttt ttt t(SEQ ID No.9)。在确认凝胶电泳可以观测成环和破环的变化之后,合成这套模板和发夹接头,以模拟基因检测血中游离核酸时的实际情形。The hairpin linker sequence is as follows: P-aaa aaa aaa aag/i5medc/a/i5medc/a/i5medc/i5medc/gta/i5medc/t/i5medc/a/i5medc/t/i5medc/i5medc/gagttggatg/i5medc/ tgg atg gtt ttt ttt ttt t (SEQ ID No. 9). After confirming that the gel electrophoresis can observe the changes in ring formation and destruction, this set of templates and hairpin adapters were synthesized to simulate the actual situation of gene detection of free nucleic acids in the blood.
1.连接反应体系如下:1. The connection reaction system is as follows:
Figure PCTCN2021091723-appb-000004
Figure PCTCN2021091723-appb-000004
Figure PCTCN2021091723-appb-000005
Figure PCTCN2021091723-appb-000005
反应条件:25℃,2h;然后70℃,20min,使T4 DNA连接酶失去活性。Reaction conditions: 25°C, 2h; then 70°C, 20min, to inactivate T4 DNA ligase.
2.加入1μl AciI限制性内切酶酶切连接产物,37℃,2h,70℃,20min,使AciI内切酶失去活性。2. Add 1μl AciI restriction endonuclease to digest the ligation product, 37°C, 2h, 70°C, 20min to inactivate the AciI endonuclease.
3.将消化后的酶切产物进行凝胶电泳鉴定,电泳条件为100V,30min,2%琼脂糖凝胶。电泳结果见图3A。3. The digested products were identified by gel electrophoresis, the electrophoresis conditions were 100V, 30min, 2% agarose gel. The results of electrophoresis are shown in Figure 3A.
图3A:左边第一泳道是100碱基DNA大小标志,最亮的两条条带分别为500和1000碱基。泳道2,5,7为短模板与接头混合物;连接酶链接后线性模板与2个接头连接成环形结构,位于100碱基参照物大小附近(泳道3,6,9);中间一条条带为模板与一个接头连接的发夹形产物,限制性内切酶AciI消化后,只有甲基化模板所形成的环形分子仍保持环形结构(泳道4)。非甲基化短模板与接头形成的环状结构在AciI消化后重新变为线性,且分子大小相差14个碱基的两个小片段,重叠同一凝胶条带中。连接酶连接后和AciI消化后仍可见的最小条带为多余的接头分子。上述结果表明成环和破环过程可以区分甲基化与非甲基化的核酸分子。Figure 3A: The first lane on the left is the 100-base DNA size marker, and the two brightest bands are 500 and 1000 bases, respectively. Lanes 2, 5, and 7 are the mixture of short template and linker; after ligase linking, the linear template and two linkers are connected to form a circular structure, which is located near the size of the 100 base reference substance (lanes 3, 6, 9); the middle band is After the hairpin-shaped product connected to the template and a linker, after digestion with the restriction enzyme AciI, only the ring molecule formed by the methylated template still maintains the ring structure (lane 4). The loop structure formed by the unmethylated short template and the linker becomes linear again after AciI digestion, and two small fragments with a difference of 14 bases in molecular size overlap the same gel band. The smallest band still visible after ligase ligation and AciI digestion is the excess linker molecule. The above results indicate that the process of ring formation and destruction can distinguish between methylated and unmethylated nucleic acid molecules.
4.将上述酶切产物稀释1000倍,进行滚环扩增,扩增试剂盒购自新海基因公司(批号A3702),体系如下:4. Dilute the above-mentioned enzyme digestion product by 1000 times and carry out rolling circle amplification. The amplification kit was purchased from Xinhai Gene Corporation (lot number A3702), and the system is as follows:
Figure PCTCN2021091723-appb-000006
Figure PCTCN2021091723-appb-000006
反应程序:95℃,3min;25℃,5min;加入BSA与phi29,30℃,14h。Reaction procedure: 95°C, 3min; 25°C, 5min; adding BSA and phi29, 30°C, 14h.
5.取5ul滚环扩增产物进行电泳鉴定,电泳条件为100V,30min,0.8%浓度琼脂糖 凝胶。电泳结果见图3B。5. Take 5ul of rolling circle amplification product for electrophoresis identification, the electrophoresis conditions are 100V, 30min, 0.8% concentration agarose gel. The results of electrophoresis are shown in Figure 3B.
图3B为破环后的滚环扩增,含有千分之一甲基化模板的混合标本,得到可见的扩增产物(泳道2);纯甲基化标本扩增产物最多(泳道4),纯非甲基化模板基本未见扩增产物(泳道3)。Figure 3B shows the rolling circle amplification after the ring is broken. A mixed sample containing one-thousandth of a methylated template yields visible amplification products (lane 2); pure methylated samples have the most amplification products (lane 4). There was almost no amplification product in the pure unmethylated template (lane 3).
实施例三:EGFR18碱基缺失突变的识别。Example 3: Identification of EGFR18 base deletion mutations.
1.待测模板的配置:配制野生型、突变型和50%比50%为测试标本。模板序列分别为:1. Configuration of test template: prepare wild type, mutant type and 50% to 50% as test specimens. The template sequences are:
EGFR-exon19-wt:atctcacaattgccagttaacgtcttccttctctctctgtcatagGGACTCTGGATCCCAGAAGGTGAGAAAGTTAAAATTCCCG TCGCTATCAAGGAATTAAGAGAAGCAACATCTCCGAAAGCCAACAAGGAAATCCTCGATgtgagtttctgctttgctgtgtgggggtccatggctctgaacctcaggcccaccttttctcatgtctggcagct(SEQ ID No.10)(图中下划线标记部分为guide RNA的靶向序列) EGFR-exon19-wt:atctcacaattgccagttaacgtcttccttctctctctgtcatagGGACTCTGGATCCCAGAAGGTGAGAAAGTTAAAATTCCCG TCGCTATCAAGGAATTAAGA GAAGCAACATCTCCGAAAGCCAACAAGGAAATCCTgtgtctggaccttctgtctggaccttccagtctggaccttccagtctggaccttccagtctggaccttcca ct ct in the figure (SEQ ct gtctggaccttcca gtctggaccttcca ctggacctcca)
EGFR-exon19-del18:EGFR-exon19-del18:
atctcacaattgccagttaacgtcttccttctctctctgtcatagGGACTCTGGATCCCAGAAGGTGAGAAAGTTAAAATTCCCGTCGCTATCAAGGAAT------------------CGAAAGCCAACAAGGAAATCCTCGATgtgagtttctgctttgctgtgtgggggtccatggctctgaacctcaggcccaccttttctcatgtctggcagct(SEQ ID No.11)(图中缺失为18bp碱基的缺失)atctcacaattgccagttaacgtcttccttctctctctgtcatagGGACTCTGGATCCCAGAAGGTGAGAAAGTTAAAATTCCCGTCGCTATCAAGGAAT------------------CGAAAGCCAACAAGGAAATCCTCGATgtgagtttctgctttgctgtgtgggggtccatggctctctctgtgtggccggtccatggctctctctgtgtggggggtccatggctctctctgtgtggccdelection in the figure 11 (base in the figure is missing) ccatggctctgaacctcaggcccaccttct.
guide RNA转录模板:guide RNA transcription template:
GAATTCTAATACGACTCACTATAGCTTAATTCCTTGATAGCGAGTTTAAGAGCTATGCTGGAAACAGC(SEQ ID No.12)GAATTCTAATACGACTCACTATAGCTTAATTCCTTGATAGCGAGTTTAAGAGCTATGCTGGAAACAGC (SEQ ID No. 12)
采用5’带有EcoRI酶切位点的引物对待测模板进行PCR反应。引物序列分别为:Use 5'primers with EcoRI restriction site to perform PCR reaction on the template to be tested. The primer sequences are:
正向引物: ggaggaaTTCGGAGTGAGTACGGTGTGC  CCCAGAAGGTGAGAAAGTT(SEQ ID No.13)(图中下划线标记为EcoRI限制性酶切位点); Forward primer: ggaggaaTTC GGAGTGAGTACGGTGTGC CCCAGAAGGTGAGAAAGTT (SEQ ID No. 13) (the underline in the figure indicates the EcoRI restriction site);
反向引物:ggaggaaTTC GAGTTGGATGCTGGATGG  agaaa ctc acat cgagg atttc(SEQ ID No.14)(图中下划线标记为EcoRI限制性酶切位点)。 Reverse primer: ggaggaaTTC GAGTTGGATGCTGGATGG agaaa ctc acat cgagg atttc (SEQ ID No. 14) (the underline in the figure is the EcoRI restriction site).
2.PCR反应条件如下:2. PCR reaction conditions are as follows:
Figure PCTCN2021091723-appb-000007
Figure PCTCN2021091723-appb-000007
Figure PCTCN2021091723-appb-000008
Figure PCTCN2021091723-appb-000008
PCR反应程序为:98℃,30s;98℃,10s,60℃,15s,72℃,10s;72℃,3分钟;循环数为35次。The PCR reaction program is: 98°C, 30s; 98°C, 10s, 60°C, 15s, 72°C, 10s; 72°C, 3 minutes; the number of cycles is 35 times.
取纯化后的PCR反应产物加入限制性内切酶EcoRI消化,消化条件如下:Take the purified PCR reaction product and digest it with restriction enzyme EcoRI. The digestion conditions are as follows:
Figure PCTCN2021091723-appb-000009
Figure PCTCN2021091723-appb-000009
反应条件:37℃,1hReaction conditions: 37℃, 1h
3.将EcoRI消化后的产物70℃,20分钟处理,使EcoRI失去活性。3. Treat the product after EcoRI digestion at 70°C for 20 minutes to inactivate EcoRI.
4.预先制备guide RNA:使用体外转录试剂盒转化guide RNA的DNA模板,纯化后分装保存在-80℃。进行Cas9核酸酶体外酶切反应:在上述消化体系中加入250ng guide RNA和100ng Cas9蛋白(Cas9核酸酶,S.pyogenes,NEB#M0386M),37℃,2小时,接着70℃,20分钟,使Cas9蛋白失去活性。4. Pre-preparation of guide RNA: Use an in vitro transcription kit to transform the DNA template of guide RNA, and store it in aliquots at -80°C after purification. Carry out Cas9 nuclease in vitro digestion reaction: add 250ng guide RNA and 100ng Cas9 protein (Cas9 nuclease, S.pyogenes, NEB#M0386M) to the above digestion system, 37°C, 2 hours, then 70°C, 20 minutes, The Cas9 protein loses its activity.
5.对上述各步骤后的DNA产物进行凝胶电泳,电泳条件为100V,30min,2%琼脂糖凝胶。电泳结果见图4。5. Carry out gel electrophoresis on the DNA products after the above steps, the electrophoresis conditions are 100V, 30min, 2% agarose gel. The results of electrophoresis are shown in Figure 4.
图4为EGFR18碱基缺失突变的成环破环识别。泳道1为核酸大小标志物。泳道2,5,8为线性状态的PCR产物。泳道3,6,9为连接酶链接后的环形DNA,条带滞后于线性DNA泳道4,7,10为cas9消化后的产物,突变产物不被cas9消化(泳道4);野生产物被cas9消化由环状变为线性(泳道7);野生突变各一半的模板得到的产物部分环形DNA变为线性,显示为两条核酸条带(泳道10)。核酸成环/破环对EGFR18碱基突变与野生片段可以进行区分。Figure 4 shows the ring-forming and breaking recognition of EGFR18 base deletion mutations. Lane 1 is the nucleic acid size marker. Lanes 2, 5, and 8 are PCR products in a linear state. Lanes 3, 6, and 9 are the circular DNA linked by ligase, and the bands are lagging behind the linear DNA. Lanes 4, 7, and 10 are the products after cas9 digestion. The mutant products are not digested by cas9 (lane 4); wild products are digested by cas9 The circular DNA becomes linear (lane 7); the part of the circular DNA obtained from the wild mutant half of the template becomes linear, showing two nucleic acid bands (lane 10). Nucleic acid looping/breaking can distinguish EGFR18 base mutations from wild fragments.
实施例四:EGFR18碱基缺失突变分析,cas9消化,含千分之一突变,滚环扩增一代测序Example 4: EGFR18 base deletion mutation analysis, cas9 digestion, containing one-thousandth mutation, rolling circle amplification first-generation sequencing
1.配制EGFR-19号外显子野生型(1pg),突变型(1pg),和0.1%突变型PCR产物为测试标本。模板序列为:1. Prepare EGFR-19 exon wild-type (1pg), mutant (1pg), and 0.1% mutant PCR products as test specimens. The template sequence is:
EGFR-exon19-wt:atctcacaattgccagttaacgtcttccttctctctctgtcatagGGACTCTGGATCCCAGAAGGTGAGAAAGTTAAAATTCCCG TCGCTATCAAGGAATTAAGAGAAGCAACATCTCCGAAAGCCAACAAGGAAATCCTCGATgtgagtttctgctttgctgtgtgggggtccatggctctgaacctcaggcccaccttttctcatgtctggcagct(SEQ ID No.10)(图中下划线标记部分为 guide RNA的靶向序列) EGFR-exon19-wt:atctcacaattgccagttaacgtcttccttctctctctgtcatagGGACTCTGGATCCCAGAAGGTGAGAAAGTTAAAATTCCCG TCGCTATCAAGGAATTAAGA GAAGCAACATCTCCGAAAGCCAACAAGGAAATCCTgtgtctggaccttctgtctggaccttccagtctggaccttccagtctggaccttccagtctggaccttcca ct ct in the figure (SEQ ct gtctggaccttcca gtctggaccttcca ctggacctcca)
EGFR-exon19-del18:EGFR-exon19-del18:
atctcacaattgccagttaacgtcttccttctctctctgtcatagGGACTCTGGATCCCAGAAGGTGAGAAAGTTAAAATTCCCGTCGCTATCAAGGAAT------------------CGAAAGCCAACAAGGAAATCCTCGATgtgagtttctgctttgctgtgtgggggtccatggctctgaacctcaggcccaccttttctcatgtctggcagct(SEQ ID No.11)(图中缺失部分为18bp碱基的缺失)atctcacaattgccagttaacgtcttccttctctctctgtcatagGGACTCTGGATCCCAGAAGGTGAGAAAGTTAAAATTCCCGTCGCTATCAAGGAAT------------------CGAAAGCCAACAAGGAAATCCTCGATgtgagtttctgctttgctgtgtggccggtccatggctctgaacctcaggccggtccatggctctctctgtgtggccdelection of bases in the figure 11 (bp gt ct ctctgaacctcaggcccaccttct18)
guide RNA转录模板:GAATTCTAATACGACTCACTATAGCTTAATTCCTTGATAGCGAGTTTAAGAGCTATGCTGGAAACAGC(SEQ ID No.12)guide RNA transcription template: GAATTCTAATACGACTCACTATAGCTTAATTCCTTGATAGCGAGTTTAAGAGCTATGCTGGAAACAGC (SEQ ID No. 12)
2.采用5’带有EcoRI酶切位点的引物对待测模板进行PCR反应。引物序列分别为:2. Use 5'primers with EcoRI restriction sites to perform PCR reaction on the template to be tested. The primer sequences are:
正向引物: ggaggaaTTC GGAGTGAGTACGGTGTGC  CCCAGAAGGTGAGAAAGTT(SEQ ID No.13)(图中下划线标注为EcoRI限制性酶切位点); Forward primer: ggaggaaTTC GGAGTGAGTACGGTGTGC CCCAGAAGGTGAGAAAGTT (SEQ ID No. 13) (the underline in the figure indicates the EcoRI restriction site);
反向引物:ggaggaaTTC GAGTTGGATGCTGGATGG  agaaa ctc acat cgagg atttc(SEQ ID No.14)(图中下划线标注为EcoRI限制性酶切位点)。 Reverse primer: ggaggaaTTC GAGTTGGATGCTGGATGG agaaa ctc acat cgagg atttc (SEQ ID No. 14) (the underline in the figure indicates the EcoRI restriction site).
PCR反应条件如下:The PCR reaction conditions are as follows:
Figure PCTCN2021091723-appb-000010
Figure PCTCN2021091723-appb-000010
PCR反应程序为:98℃,30s;98℃,10s,60℃,15s,72℃,10s;72℃,3分钟;循环数为35次。The PCR reaction program is: 98°C, 30s; 98°C, 10s, 60°C, 15s, 72°C, 10s; 72°C, 3 minutes; the number of cycles is 35 times.
3.取纯化后的PCR反应产物加入限制性内切酶EcoRI消化,消化条件如下:3. Take the purified PCR reaction product and digest it with restriction enzyme EcoRI. The digestion conditions are as follows:
Figure PCTCN2021091723-appb-000011
Figure PCTCN2021091723-appb-000011
反应条件:37℃,1小时。Reaction conditions: 37°C, 1 hour.
4.将EcoRI消化后的产物摄氏80度20分钟处理,使EcoRI失去活性。4. Treat the digested product of EcoRI at 80 degrees Celsius for 20 minutes to inactivate EcoRI.
5.预先制备guide RNA:使用体外转录试剂盒转化guide RNA的DNA模板,纯化后分装保存在-80℃。进行Cas9核酸酶体外酶切反应:在上述消化体系中加入250ng guide RNA和100ng Cas9蛋白(Cas9核酸酶,S.pyogenes,NEB#M0386M),37℃,2 小时,接着70℃,20分钟,使Cas9蛋白失去活性。5. Pre-preparation of guide RNA: Use an in vitro transcription kit to transform the DNA template of guide RNA, and store it in aliquots at -80°C after purification. Carry out Cas9 nuclease in vitro digestion reaction: add 250ng guide RNA and 100ng Cas9 protein (Cas9 nuclease, S.pyogenes, NEB#M0386M) to the above digestion system, 37°C, 2 hours, then 70°C, 20 minutes, The Cas9 protein loses its activity.
6.将上述酶切产物稀释1000倍,进行滚环扩增,扩增试剂盒购自新海基因公司(批号A3702),体系如下:6. Dilute the above-mentioned enzyme digestion product by 1000 times, and carry out rolling circle amplification. The amplification kit was purchased from Xinhai Gene Corporation (batch number A3702). The system is as follows:
Figure PCTCN2021091723-appb-000012
Figure PCTCN2021091723-appb-000012
反应程序:95℃,3min;25℃,5min;加入BSA与phi29,30℃,14h。Reaction procedure: 95°C, 3min; 25°C, 5min; adding BSA and phi29, 30°C, 14h.
7.取5μl滚环扩增产物进行电泳鉴定,电泳条件为100V,30min,0.8%浓度琼脂糖凝胶。电泳结果见图5A。从图5A可见,滚环扩增后可以明显区分野生,突变,和含有少量突变的混合标本。扩增产物突变标本最多(泳道2),混合标本有明显的扩增长片段条带产物(泳道4),野生标本仅见极微量的长片段扩增产物和少许超长扩增产物滞留在上样孔内(泳道3)。7. Take 5μl of rolling circle amplification products for electrophoresis identification, the electrophoresis conditions are 100V, 30min, 0.8% concentration agarose gel. The results of electrophoresis are shown in Figure 5A. It can be seen from Figure 5A that after rolling circle amplification, wild, mutant, and mixed specimens with a small amount of mutations can be clearly distinguished. The most amplified product mutant specimens (lane 2), mixed specimens have obvious amplified long fragment band products (lane 4), wild specimens only saw a very small amount of long fragment amplified products and a few ultra-long amplified products remained in the sample Inside the hole (lane 3).
将含千分之一突变混合标本的最后一步PCR扩增产物送公司进行一代测序,测序结果见图5B测序图:一代测序结果显示含有千分之一突变模板的标本,滚环扩增的产物表现为突变序列的单一峰。说明成环/破环/滚环扩增三步骤之后,突变片段得到了富集。The final PCR amplification product of the mixed sample containing one-thousandth mutation is sent to the company for first-generation sequencing. The sequencing result is shown in Figure 5B. Sequencing diagram: The first-generation sequencing result shows that the sample containing one-thousandth mutation template is the product of rolling circle amplification. Appears as a single peak of the mutant sequence. It shows that after the three steps of looping/breaking/rolling circle amplification, the mutant fragments are enriched.
实施例五:EGFRT790M 2369C>T热点突变分析Example 5: EGFRT790M 2369C>T hot spot mutation analysis
1.配制EGFR790野生型(1pg),突变型(1pg),和0.1%突变型的PCR产物为测试标本。模板序列分别为:1. Prepare EGFR790 wild-type (1pg), mutant (1pg), and 0.1% mutant PCR products as test specimens. The template sequences are:
EGFR790-wt:EGFR790-wt:
TCTCCCTCCCTCCAGGAAGCCTACGTGATGGCCAGCGTGGACAACCCCCACGTGTGCCGCCTGCTGGGCATCTGCCTCACCTCCACCGTGCAGCTCATCA CGCAGCTCATGCCCTTCGGCTGCCTCCTGGACTATGTCCGGGAACACAAAGACAATATTGGCTCCCAGTACCTGCTCAACTGGTGTGTGCAGATCGCAAAG(SEQ ID No.15)(图中带下划线为突变的碱基) TCTCCCTCCCTCCAGGAAGCCTACGTGATGGCCAGCGTGGACAACCCCCACGTGTGCCGCCTGCTGGGCATCTGCCTCACCTCCACCGTGCAGCTCATCA C GCAGCTCATGCCCTTCGGCTGCCTCCTGGACTATGTCCGGGAACACAAAGACAATATTGGCTCCCAGTACCTGCTCAACTGGTG (the base line in the figure below is the base line with the base No. ID in the SEQ ID No.
EGFR790-mut:EGFR790-mut:
TCTCCCTCCCTCCAGGAAGCCTACGTGATGGCCAGCGTGGACAACCCCCACGTGTGCCGCCTGCTGGGCATCTGCCTCACCTCCACCGTGCAGCTCATCA TGCAGCTCATGCCCTTCGGCTGCCTCCTGGACTATGTCCGGGAACACAAAGACAATATTGGCTCCCAGTACCTGCTCAACTGGTGTGTGCAGATCGCAAAG(SEQ ID No.16)(图中带下划线为突变的碱基) TCTCCCTCCCTCCAGGAAGCCTACGTGATGGCCAGCGTGGACAACCCCCACGTGTGCCGCCTGCTGGGCATCTGCCTCACCTCCACCGTGCAGCTCATCA T GCAGCTCATGCCCTTCGGCTGCCTCCTGGACTATGTCCGGGAACACAAAGACAATATTGGCTCCCAGTACCTGCTCAACTGGTG is the base line in the figure with the base line No. in the SEQ ID No.
2.采用5’带有EcoRI酶切位点的引物对待测模板进行PCR反应。引物序列分别为:2. Use 5'primers with EcoRI restriction sites to perform PCR reaction on the template to be tested. The primer sequences are:
正向引物:GGAG GAATTCGTTATCAGTTATCTCCACCGTGCAGCTCATCC(SEQ ID No.17)(图中标注为EcoRI限制性酶切位点,C为引入的突变碱基);和 Forward primer: GGAG GAATTC GTTATCAGTTATCTCCACCGTGCAGCTCATCC (SEQ ID No. 17) (marked as EcoRI restriction site in the figure, C is the introduced mutation base); and
反向引物:GGAG GAATTCGTTATCAGTTATAGCCGAAGGGCATGAGCTCC(SEQ ID No.18)(图中标注为EcoRI限制性酶切位点,C为引入的突变碱基)。 Reverse primer: GGAG GAATTC GTTATCAGTTATAGCCGAAGGGCATGAGCTCC (SEQ ID No. 18) (marked as EcoRI restriction site in the figure, C is the introduced mutation base).
PCR反应条件如下:The PCR reaction conditions are as follows:
Figure PCTCN2021091723-appb-000013
Figure PCTCN2021091723-appb-000013
PCR反应程序为:预变性:95℃,3min;95℃,20s,58℃,20s,72℃,20s;72℃,3min;循环数为35次。The PCR reaction program is: pre-denaturation: 95°C, 3min; 95°C, 20s, 58°C, 20s, 72°C, 20s; 72°C, 3min; the number of cycles is 35 times.
3.纯化PCR反应产物,使用限制性内切酶EcoRI消化,消化条件如下:3. Purify the PCR reaction product and digest it with the restriction enzyme EcoRI. The digestion conditions are as follows:
Figure PCTCN2021091723-appb-000014
Figure PCTCN2021091723-appb-000014
反应条件:37℃,1小时Reaction conditions: 37°C, 1 hour
4.将EcoRI消化后的产物摄氏80度20分钟处理,使EcoRI失去活性。4. Treat the digested product of EcoRI at 80 degrees Celsius for 20 minutes to inactivate EcoRI.
5.将上述内切酶消化产物进行环化处理;环化反应条件如下:5. The above endonuclease digestion products are subjected to cyclization treatment; the cyclization reaction conditions are as follows:
加入终浓度为1mM的ATP与0.4μl T4 DNA连接酶,25℃,1小时,接着70℃,20min处理,使T4 DNA连接酶失去活性。Add ATP with a final concentration of 1mM and 0.4μl T4 DNA ligase at 25°C for 1 hour, followed by treatment at 70°C for 20 minutes to inactivate T4 DNA ligase.
6.环化处理后的产物采用限制性内切酶NciI消化,消化条件如下:6. The product after cyclization is digested with restriction enzyme NciI, and the digestion conditions are as follows:
加入0.4ul NciI限制性内切酶,37℃,1h,70℃,20分钟处理,使NciI失去活性。Add 0.4ul NciI restriction endonuclease and treat it at 37°C, 1h, 70°C, 20 minutes to inactivate NciI.
7.取0.1ul消化后产物进行滚环扩增,扩增条件如下:7. Take 0.1ul of the digested product for rolling circle amplification, and the amplification conditions are as follows:
Figure PCTCN2021091723-appb-000015
Figure PCTCN2021091723-appb-000015
反应程序:95℃,3分钟;25℃,5分钟;加入BSA与phi29,30℃,14小时。Reaction procedure: 95°C, 3 minutes; 25°C, 5 minutes; adding BSA and phi29, 30°C, 14 hours.
对滚环扩增产物电泳,电泳条件为100V,30分钟,0.8%琼脂糖凝胶。凝胶电泳结果见图6A:泳道2是含千分之一突变的混合模板,泳道3是突变模板,泳道4是野生模板。野生模板扩增产物最少。左侧第一泳道为kb大小的DNA标志。在滚环扩增中后,含有千分之一突变混合模板(泳道2)和突变模板(泳道3)的滚环扩增产物显著多于野生标本(泳道4)。滚环扩增后产物的量三个标本之间差异明显。For electrophoresis of rolling circle amplification products, the electrophoresis conditions were 100V, 30 minutes, and 0.8% agarose gel. The results of gel electrophoresis are shown in Figure 6A: Lane 2 is a mixed template containing one-thousandth mutations, Lane 3 is a mutant template, and Lane 4 is a wild template. Wild template amplification products are the least. The first lane on the left is the kb DNA marker. After rolling circle amplification, there were significantly more rolling circle amplification products containing one-thousandth of the mutant mixed template (lane 2) and mutant template (lane 3) than the wild specimen (lane 4). The amount of product after rolling circle amplification was significantly different among the three specimens.
将含千分之一突变混合标本的滚环扩增产物进行一代测序,测序结果见图6B。The rolling circle amplification products of the mixed sample containing one-thousandth mutations were subjected to first-generation sequencing, and the sequencing results are shown in Figure 6B.
图6B:含有0.1%突变模板混合标本的滚环扩增产物经测序,确认为来自于突变模板且未显示混合的套峰,表明扩增产物中突变分子的含量得到了富集。Figure 6B: After sequencing, the rolling circle amplification product of the mixed sample containing 0.1% mutant template was confirmed to be derived from the mutant template and did not show a mixed set of peaks, indicating that the content of mutant molecules in the amplified product was enriched.
以上显示和描述了本发明的基本原理、主要特征和本发明的优点。本行业的技术人员应该了解,本发明不受上述实例的限制,上述实例和说明书中描述的只是说明本发明的原理,在不脱离本发明精神和范围的前提下本发明还会有各种变化和改进,这些变化和改进都落入要求保护的本发明范围内。本发明要求保护范围由所附的权利要求书及其等同物界定。The basic principles, main features and advantages of the present invention have been shown and described above. Those skilled in the industry should understand that the present invention is not limited by the above examples. The above examples and descriptions only illustrate the principles of the present invention. The present invention will have various changes without departing from the spirit and scope of the present invention. And improvements, these changes and improvements all fall within the scope of the claimed invention. The scope of protection claimed by the present invention is defined by the appended claims and their equivalents.

Claims (7)

  1. 多种混合核酸中检测痕量核酸的方法,其包括如下步骤:The methods for detecting trace amounts of nucleic acids in a variety of mixed nucleic acids include the following steps:
    (1)对待测样本中的线性核酸分子进行环化处理,(1) The linear nucleic acid molecules in the sample to be tested are circularized,
    (2)对环化后的核酸进行选择性的破环处理,使待测样本中不需要富集的核酸靶点从环形核酸变为线性核酸,(2) Carry out selective destruction treatment on the circularized nucleic acid, so that the nucleic acid target that does not need to be enriched in the sample to be tested changes from circular nucleic acid to linear nucleic acid,
    (3)对步骤(2)得到的核酸分子进行检测识别,检测存留形态是线性核酸还是环形核酸。(3) Detect and identify the nucleic acid molecules obtained in step (2), and detect whether the remaining form is linear nucleic acid or circular nucleic acid.
  2. 根据权利要求1所述的检测痕量核酸的方法,其特征在于,当需要识别与富集的核酸靶点为大量长度不一的未知情况时,在步骤(1)前,先将待测样本中的线性核酸分子的末端填平补A,然后用核酸连接酶链接接头以形成环化核酸。The method for detecting trace amounts of nucleic acid according to claim 1, wherein when the nucleic acid target to be identified and enriched is a large number of unknowns with different lengths, before step (1), the sample to be tested Fill in the end of the linear nucleic acid molecule in A, and then link the linker with a nucleic acid ligase to form a circularized nucleic acid.
  3. 根据权利要求1所述的检测痕量核酸的方法,其特征在于,当需要识别与富集的核酸为已知确定数量的靶点时,在步骤(1)前,先采用5’末端带限制性内切酶位点的引物进行扩增,然后利用相应的内切酶处理扩增产物、然后采用核酸连接酶使其形成环化核酸。The method for detecting trace amounts of nucleic acid according to claim 1, wherein when the nucleic acid to be identified and enriched is a known and determined number of targets, before step (1), a 5'end band restriction is used. The primers of the sex endonuclease site are amplified, and then the amplified product is treated with the corresponding endonuclease, and then the nucleic acid ligase is used to form circularized nucleic acid.
  4. 根据权利要求1所述的检测痕量核酸的方法,其特征在于,当需要富集的核酸为已知的一定数量的靶点时,在步骤(1)前,采用5’末端带LoxP位点的引物进行扩增,然后利用cre重组酶的重组功能形成环化核酸。The method for detecting trace amounts of nucleic acid according to claim 1, wherein when the nucleic acid to be enriched is a known number of targets, before step (1), a LoxP site at the 5'end is used The primers are amplified, and then the recombination function of cre recombinase is used to form circular nucleic acid.
  5. 根据权利要求1所述的检测痕量核酸的方法,其特征在于,在步骤(2),所述具有核酸内切功能的核酸酶为天然核酸内切酶或基因工程核酸内切酶。The method for detecting trace amounts of nucleic acid according to claim 1, wherein in step (2), the nuclease with endonuclease function is a natural endonuclease or a genetically engineered endonuclease.
  6. 根据权利要求1所述的检测痕量核酸的方法,其特征在于,在步骤(3)中,对待测核酸分子进行识别的存留形态是线性还是环形的方法,包括电泳方法、核酸外切酶外切法、PCR扩增法、滚环扩增法、飞行质谱、高压液相法、高分辨溶解曲线。The method for detecting trace amounts of nucleic acid according to claim 1, wherein in step (3), the method of identifying whether the remaining form of the nucleic acid molecule to be tested is linear or circular, including electrophoresis, exonuclease Excision method, PCR amplification method, rolling circle amplification method, flight mass spectrometry, high pressure liquid method, high resolution melting curve.
  7. 根据权利要求1所述的检测痕量核酸的方法,其特征在于,对选择性破环后的待测样本进行滚环扩增。The method for detecting trace amounts of nucleic acid according to claim 1, wherein the sample to be tested after selective destruction is subjected to rolling circle amplification.
PCT/CN2021/091723 2020-06-17 2021-04-30 Method for detecting trace nucleic acids in various mixed nucleic acids WO2021254009A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN202010552778.9A CN111876472B (en) 2020-06-17 2020-06-17 Method for detecting trace nucleic acid in multiple mixed nucleic acids
CN202010552778.9 2020-06-17

Publications (1)

Publication Number Publication Date
WO2021254009A1 true WO2021254009A1 (en) 2021-12-23

Family

ID=73156806

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2021/091723 WO2021254009A1 (en) 2020-06-17 2021-04-30 Method for detecting trace nucleic acids in various mixed nucleic acids

Country Status (2)

Country Link
CN (1) CN111876472B (en)
WO (1) WO2021254009A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111876472B (en) * 2020-06-17 2023-12-01 江门市灿明生物科技有限公司 Method for detecting trace nucleic acid in multiple mixed nucleic acids

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101421410A (en) * 2006-03-06 2009-04-29 纽约市哥伦比亚大学托管会 Specific amplification of fetal DNA sequences from a mixed, fetal-maternal source
WO2019117714A1 (en) * 2017-12-11 2019-06-20 Umc Utrecht Holding B.V. Methods for preparing nucleic acid molecules for sequencing
CN111876472A (en) * 2020-06-17 2020-11-03 李凯 Method for detecting trace nucleic acid in multiple mixed nucleic acids

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2540087A1 (en) * 2003-09-26 2005-04-07 Circleamp, Inc. Amplification of polynucleotides by rolling circle amplification
CN101041850A (en) * 2006-03-20 2007-09-26 吕成伟 T790M mutation quick-detection method and reagent case for human epidermal growth factor acceptor(EGFR) gene extron 20
KR101414713B1 (en) * 2007-10-11 2014-07-03 삼성전자주식회사 Method of amplifying target nucleic acids by rolling circle amplification in the presence of ligase and endonuclease
CN103131779A (en) * 2013-02-25 2013-06-05 深圳市宝安区人民医院 Enzyme digestion enriched PCR method used in noninvasive detection of epidermal growth factor receptor T790M mutation
CN104087655B (en) * 2014-03-26 2016-04-13 关一夫 Based on the analytical procedure that the restriction endonuclease strand of rolling circle amplification cuts
CN105255858B (en) * 2015-10-20 2020-03-31 郴州市第一人民医院 Method for transforming nucleic acid genotype
EP3371326B1 (en) * 2015-11-05 2023-11-01 Global Life Sciences Solutions Operations UK Ltd Ligase-assisted nucleic acid circularization and amplification
CN105695571A (en) * 2016-01-29 2016-06-22 苏州金唯智生物科技有限公司 DNA quantitative method based on rolling circle amplification
CN105821120B (en) * 2016-02-03 2019-04-30 广州医科大学附属肿瘤医院 A kind of T790M mutation detection methods based on the compound COLD-PCR of nido
CN110734969A (en) * 2017-04-21 2020-01-31 武汉科技大学 PCR-RFLP method for detecting single nucleotide polymorphism of gene CREB1
CN108103163A (en) * 2018-01-17 2018-06-01 湖南大地同年生物科技有限公司 A kind of detection method of gene methylation

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101421410A (en) * 2006-03-06 2009-04-29 纽约市哥伦比亚大学托管会 Specific amplification of fetal DNA sequences from a mixed, fetal-maternal source
WO2019117714A1 (en) * 2017-12-11 2019-06-20 Umc Utrecht Holding B.V. Methods for preparing nucleic acid molecules for sequencing
CN111876472A (en) * 2020-06-17 2020-11-03 李凯 Method for detecting trace nucleic acid in multiple mixed nucleic acids

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
SH LEE ET AL.: "CUT-PCR: CRISPR-mediated, ultrasensitive detection of target DNA using PCR", ONCOGENE, vol. 36, no. 49, 28 August 2017 (2017-08-28), pages 6823 - 6829, XP055779070, DOI: 10.1038/onc.2017.281 *

Also Published As

Publication number Publication date
CN111876472A (en) 2020-11-03
CN111876472B (en) 2023-12-01

Similar Documents

Publication Publication Date Title
WO2020056924A1 (en) Method for detecting nucleic acid
JP6224689B2 (en) Methods and compositions for distinguishing cytosine from modifications thereof and for methylome analysis
CN111094565B (en) Guiding nucleic acid production and use
JP2018500937A (en) Compositions and methods for targeted depletion, enrichment and resolution of nucleic acids using CRISPR / CAS-based proteins
US20070172839A1 (en) Asymmetrical adapters and methods of use thereof
CN116064730A (en) Method for nucleic acid enrichment using site-specific nucleases and subsequent capture
PT2963709T (en) Transposon end compositions and methods for modifying nucleic acids
WO2013064066A1 (en) Method for constructing methylated high-throughput sequencing library for whole genome and use thereof
US20230056763A1 (en) Methods of targeted sequencing
WO2019224560A1 (en) Method
US11802282B2 (en) Method for identifying gene fusions by circle cDNA amplification
JP2012510810A (en) Method for reducing repetitive sequences in adapter-linked restriction fragments
US20100286379A1 (en) Bisulphite treatment of rna
US20220033879A1 (en) Targeted enrichment by endonuclease protection
WO2012037881A1 (en) Nucleic acid tags and use thereof
WO2021254009A1 (en) Method for detecting trace nucleic acids in various mixed nucleic acids
WO2019217785A1 (en) High-throughput method for characterizing the genome-wide activity of editing nucleases in vitro
WO2017215517A1 (en) Method for removing 5' and 3' linker connection by-products in sequencing library construction
WO2024112441A1 (en) Double-stranded dna deaminases and uses thereof
WO2022199242A1 (en) Set of barcode linkers and medium-flux multi-single-cell representative dna methylation library construction and sequencing method
CN114075595B (en) Methylation detection compositions, kits, and methods
JP2005218385A (en) Method for preparing single-stranded dna
WO2020228844A2 (en) Method of testing activity of double strand break-generating reagent
WO2019233450A1 (en) Detection method for dna methylation
WO2023236618A1 (en) Pe-stop gene editing system, gene knockout method, and use

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 21825239

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205A DATED 09/05/2023)

122 Ep: pct application non-entry in european phase

Ref document number: 21825239

Country of ref document: EP

Kind code of ref document: A1